Skip to main content
Clinical Trials/NCT03246191
NCT03246191UnknownNot Applicable

Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease:a Cross - Sectional Study

Chinese PLA General Hospital0 sites900 target enrollmentStarted: August 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
900
Primary Endpoint
Prevalence of CKD complications

Study Overview

Brief Summary

The study is an observational, cross-sectional study aimed at screening and accessing risk factors and complications for Chinese chronic kidney disease (CKD) patients. To investigate the prevalence of hypertension, cardiovascular and cerebrovascular diseases, protein energy malnutrition(PEM), cognitive impairment and other complications in the CKD patients. To develop biomarkers of CKD.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age≥18 years
  • clinical diagnosis of CKD
  • signed informed consent

Exclusion Criteria

  • End-stage renal disease(ESRD) or dialysis
  • Acute kidney injure(AKI)
  • history of solid organ or bone marrow transplantation
  • active malignancy within 24 months prior to screening or metastatic cancer
  • HIV infection or AIDS
  • acute inflammation

Outcomes

Primary Outcomes

Prevalence of CKD complications

Time Frame: baseline

hypertension, cardiovascular and cerebrovascular diseases, protein energy malnutrition(PEM), cognitive impairment

Biomarkers of kidney function

Time Frame: baseline

Secondary Outcomes

  • Genetic analyses(baseline)
  • Questionnaire assessing cognitive function(baseline)
  • Questionnaire assessing depression(baseline)
  • Questionnaire assessing risk of malnutrition(baseline)
  • Questionnaire assessing dietary intake(baseline)
  • Questionnaire assessing quality of life(baseline)

Investigators

Sponsor
Chinese PLA General Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chen Xiangmei

Academician of Chinese Academy of Engineering

Chinese PLA General Hospital

Similar Trials